Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial (Q84401899)
Jump to navigation
Jump to search
scientific article published on 20 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial |
scientific article published on 20 June 2011 |
Statements
Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial (English)
Adam Christian Vilmar
Eric Santoni-Rugiu
Jens Benn Sørensen